Anti-Osteoclastogenic and Antibacterial Effects of Chlorinated Polyketides from the Beibu Gulf Coral-Derived Fungus Aspergillus unguis GXIMD 02505

Mar Drugs. 2022 Feb 28;20(3):178. doi: 10.3390/md20030178.

Abstract

One new depsidone derivative, aspergillusidone H (3), along with seven known biosynthetically related chlorinated polyketides, were obtained from the Beibu Gulf coral-derived fungus Aspergillus unguis GXIMD 02505. Their structures were determined by comprehensive physicochemical and spectroscopic data interpretation. Notably, the X-ray crystal structure of 2 and the previously unknown absolute configuration of 8, assigned by ECD calculations, are described here for the first time. Compounds 1-5, 7 and 8 exhibited inhibition of lipopolysaccharide (LPS)-induced NF-κB in RAW 264.7 macrophages at 20 μM. In addition, the two potent inhibitors (2 and 7) dose-dependently suppressed RANKL-induced osteoclast differentiation without any evidence of cytotoxicity in bone marrow macrophages cells (BMMs). This is the first report of osteoclastogenesis inhibitory activity for the metabolites of these kinds. Besides, compounds 1, 2, 4, and 6-8 showed inhibitory activity against marine biofilm-forming bacteria, methicillin-resistant Staphylococcus aureus, Microbulbifer variabilis, Marinobacterium jannaschii, and Vibrio pelagius, with their MIC values ranging from 2 to 64 μg/mL. These findings provide a basis for further development of chlorinated polyketides as potential inhibitors of osteoclast differentiation and/or for use as anti-fouling agents.

Keywords: Aspergillus unguis; antibacterial; depsides; depsidones; marine fungi; osteoclast differentiation.

MeSH terms

  • Animals
  • Anthozoa / microbiology*
  • Anti-Bacterial Agents* / chemistry
  • Anti-Bacterial Agents* / isolation & purification
  • Anti-Bacterial Agents* / pharmacology
  • Aspergillus / chemistry*
  • Bacteria / drug effects
  • Bacteria / growth & development
  • Biological Products* / chemistry
  • Biological Products* / isolation & purification
  • Biological Products* / pharmacology
  • Cells, Cultured
  • Lipopolysaccharides / pharmacology
  • Macrophages / cytology
  • Macrophages / drug effects
  • Mice
  • Molecular Structure
  • NF-kappa B / metabolism
  • Oceans and Seas
  • Osteogenesis / drug effects*
  • Polyketides* / chemistry
  • Polyketides* / isolation & purification
  • Polyketides* / pharmacology
  • RANK Ligand

Substances

  • Anti-Bacterial Agents
  • Biological Products
  • Lipopolysaccharides
  • NF-kappa B
  • Polyketides
  • RANK Ligand

Supplementary concepts

  • Aspergillus unguis